
Vomirite-MD Tablet
Marketer
Fedley Healthcare Private Limited
Salt Composition
Ondansetron (4mg)
Overview Vomirite-MD Tablet
Navras-T is an antiemetic medication frequently prescribed to manage nausea and vomiting stemming from various medical issues, including indigestion. It's also used prophylactically against nausea and vomiting triggered by surgery, cancer chemotherapy, or radiation therapy. Navras-T can be administered independently or in conjunction with other drugs, with or without food. Dosage is determined by your physician based on the treatment's purpose. The initial dose is typically given prior to surgery, chemotherapy, or radiotherapy. Subsequent doses, usually for only a few days, are administered as directed by your doctor following these procedures. For optimal results, maintain consistent daily intake. Avoid exceeding the prescribed dosage. This medication doesn't alleviate other side effects of cancer treatment and is ineffective against motion sickness-induced vomiting. Common side effects include headache, diarrhea, constipation, and fatigue, usually resolving upon discontinuation. Persistent or bothersome side effects should be discussed with your physician, who can offer strategies for mitigation. Inform your physician of any pre-existing heart or liver conditions, or stomach/intestinal obstructions, before initiating treatment. Disclose all other medications, particularly those for epilepsy, heart conditions, cancer, or depression, as interactions are possible. Consult your doctor if you are pregnant or breastfeeding.
Uses of Vomirite-MD Tablet
Managing Nausea and Vomiting
Major Benefits of Vomirite-MD Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Avoid contact with the tablets using damp hands. Place the Vomirite-MD Tablet in your mouth; however, refrain from immediate ingestion. Consumption may coincide with meals or occur independently, although consistent timing is recommended.
Common Side effects of Vomirite-MD Tablet:
- Fatigue
- Headache
- Constipation
- Diarrhea
How to use Vomirite-MD Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Avoid contact with the tablets using damp hands. Place the Vomirite-MD Tablet in your mouth; however, refrain from immediate ingestion. This medication can be consumed with or without food, though consistent timing is recommended.
How Vomirite-MD Tablet works:
Navetrol tablets offer antiemetic relief. Their mechanism involves inhibiting serotonin, a neurotransmitter in the brain that can trigger nausea and vomiting following surgery or cancer therapy (chemotherapy).
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Vomirite-MD Tablet with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Data on Vomirite-MD Tablet use in pregnancy is currently lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Vomirite-MD Tablet use while breastfeeding is absent. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Vomirite-MD Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate dosage modification for Vomirite-MD Tablets, which are considered safe for use in such patients. Nevertheless, disclosure of pre-existing kidney disease to your physician is advised. Data concerning use exceeding 24 hours are currently limited.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Vomirite-MD Tablet use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Vomirite-MD Tablet :
Should you forget a Vomirite-MD Tablet dose, take it immediately. However, near the time for your next scheduled dose, omit the missed one and resume your usual regimen. Never take a double dose.
Facts to Know About Vomirite-MD Tablet
| Label | Value |
|---|---|
| Chemical Classification | Carbazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
